Company news: Daiichi Sankyo and GCI Health

Share this article:
Daiichi Sankyo acquired a 140,000 square foot packaging and manufacturing facility in Bethlehem Township, PA for $10 million. The facility “enables DSI to leverage existing resources to more cost-effectively supplement its operations rather than build a new facility,” said the company, which expects the plant to be operational by summer or early fall and to package products including Benicar, Welchol and Azor.

North Shore-LIJ Health System named GCI Health as its PR agency of record. The company operates 15 hospitals in New York City and Long Island.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.

Insurers get personal to nip costs

Healthcare insurers seek to curb diabetes costs with interventions that may include house calls.

Novartis dials down RNA research

The drugmaker says the therapeutic approach has a narrow treatment potential.